UOC
MRTX

UBS O'Connor’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

UBS O'Connor’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q1 		– Hold
0
– – – 574
2023
Q4 		– Sell
-64,698
Closed -$2.82M – 576
2023
Q3 		$2.82M Buy
64,698
+5,000
+8% +$218K 0.05% 183
2023
Q2 		$2.16M Buy
59,698
+12,448
+26% +$450K 0.05% 280
2023
Q1 		$1.76M Buy
+47,250
New +$1.76M 0.04% 341